Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Banco de datos
Tipo del documento
Publication year range
1.
Neurobiol Aging ; 82: 60-68, 2019 10.
Artículo en Inglés | MEDLINE | ID: mdl-31404721

RESUMEN

Parkinson's disease (PD) is a common neurodegenerative disorder involving α-synuclein (α-syn) aggregation, oxidative stress, dysregulation of redox metal homeostasis, and neurotoxicity. Different phenolic compounds with known antioxidant or antichelating properties have been shown to also interfere with aggregation of amyloid proteins and modulate intracellular signaling pathways. The present study aims to investigate for the first time the effect of tyrosol (TYR), a simple phenol present in extra-virgin olive oil, on α-syn aggregation in a Caenorhabditis elegans model of PD and evaluate its potential to prevent α-syn toxicity, neurodegeneration, and oxidative stress in this model organism. Our results show that TYR is effective in reducing α-syn inclusions, resulting in a lower toxicity and extended life span of treated nematodes. Moreover, TYR delayed α-syn-dependent degeneration of dopaminergic neurons in vivo. TYR treatment also reduced reactive oxygen species level and promoted the expression of specific chaperones and antioxidant enzymes. Overall, our study puts into perspective TYR potential to be considered as nutraceutical that targets pivotal causal factors in PD.


Asunto(s)
Modelos Animales de Enfermedad , Sistemas de Liberación de Medicamentos/métodos , Aceite de Oliva/administración & dosificación , Trastornos Parkinsonianos/dietoterapia , Trastornos Parkinsonianos/patología , Alcohol Feniletílico/análogos & derivados , Animales , Animales Modificados Genéticamente , Antioxidantes/administración & dosificación , Caenorhabditis elegans , Suplementos Dietéticos , Degeneración Nerviosa/dietoterapia , Degeneración Nerviosa/metabolismo , Degeneración Nerviosa/patología , Trastornos Parkinsonianos/metabolismo , Alcohol Feniletílico/administración & dosificación , alfa-Sinucleína/antagonistas & inhibidores , alfa-Sinucleína/metabolismo
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda